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Accepted 6 November 2012AbstractObjective: Manual removal of placenta is performed in 1e3% of cases, and although it is a well-established and relatively safe procedure, it is
not without complications. We carried out this study to determine whether intraumbilical vein oxytocin injection reduces the need for manual
removal of placenta and shortens the third stage of labor, in comparison with placebo.
Materials and Methods: In this randomized clinical trial, 178 women with singleton pregnancy and normal delivery were studied in 1 year.
Immediately after fetus delivery, oxytocin infusion (20 IU/L) was started in both groups. Moreover, 10 IU oxytocin and 1 mL normal saline were
injected into the umbilical vein of women in the experimental and control groups, respectively. The duration of third-stage labor, need for
manual delivery of placenta, and drug side effects were evaluated in both groups. With regard to the mean level of hemoglobin before and after
delivery, the two groups were compared using the Levene test and independent t test, and other qualitative variables of the two groups were
compared using the c2 test.
Results: The women who received intraumbilical vein oxytocin had a shorter third stage of labor as compared with the placebo group
(4.24  3.27 min vs. 10.66  7.41) ( p < 0.001) and there was less need for manual delivery of placenta in the experiment group (1.1% vs. 5.1%)
( p ¼ 0.024).
Conclusion: It was concluded that intraumbilical vein administration of 10 IU (1 mL) oxytocin immediately after fetus delivery was clinically
effective in shortening the third stage of labor.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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The third stage of labor is defined as the period of time
between delivery of the fetus and delivery of the placenta. The
most common complication accompanying this stage is post-
partum hemorrhage (PPH), and prolonged third stage of labor
owing to placenta retention and uterine atony are among the
underlying cause of most cases of PPH. The duration of the
third stage of labor is 5e15 min; however, in 2e5% of cases,* This work was performed in partial fulfillment of the requirements for
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undertaken, these women are at risk of hemorrhage.
Currently, placenta retention is treated with manual de-
livery of placenta, which is safer to perform in an operating
room by an obstetrician assisted with anesthesia. When these
conditions are not met, the mortality rate can reach as high as
10% [1e3]. Next to oxytocin, ergot alkaloids and prosta-
glandins are, respectively, the second and third line of treat-
ment in the active management of the third stage of labor [1].
Pitocin (USP oxytocin) is a synthetic colorless, transparent
solution of oxytocin, which is found in hypophysial extract of
mammals. It has a half life of 3e5 min and can be adminis-
tered intravenously or intramuscularly [4]. The World Health
Organization (WHO) recommends active management of thecs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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istration of 10 IU oxytocin in 2 min after delivery of the fetus,
immediate clamping of the umbilical cord, and controlled
traction of the umbilical cord to prevent PPH. Injection of
additional oxytocin into the umbilical vein directs the drug to
the placental bed and uterine wall, leading to early uterine
contraction and placental detachment. Nevertheless, the papers
published on the effect of routine intraumbilical vein admin-
istration of oxytocin for management of the third stage of
labor are limited [2]. In 1995, the effect of intraumbilical vein
administration of oxytocin on the duration and blood loss of
the third stage of labor was studied in Rohtak Hospital, India.
They carried out the study on two groups of 50 pregnant
women. In the experimental group, 10 IU oxytocin diluted in
20 mL normal saline was administered via the umbilical vein
immediately after umbilical cord clamping. The women in the
control group underwent conventional placenta removal. The
third stage of labor was recorded at 1.48 and 3.27 min in the
experimental and control groups, respectively. The decrease in
the duration of the third stage of labor in the experimental
group was statistically significant. The hydraulic effect of
injected solution can contribute to placental detachment by
applying mechanical pressure [5].
According to the results obtained from evaluating 291
women with placenta retention, the need for manual removal
of placenta 30 min after fetus delivery was similar in the group
that received intraumbilical vein oxytocin and the group that
received only normal saline [6]. In spite of the availability of
placebo-controlled studies, there has been no strong result on
the effectiveness of the method, thus, further study with
respect to the determination of the appropriate dosage of
oxytocin and the effects of new techniques of modification of
oxytocin transport to placental bed needs to be conducted.
The aim of the present study was to evaluate the effect of
intraumbilical vein oxytocin on reducing the duration of the
third stage of labor and the need for manual delivery of pla-
centa, in comparison with normal saline administration.
Materials and methods
The study was approved by the Ethical Committee of
Kermanshah University of Medical Sciences. It was a ran-
domized clinical trial, carried out over 1 year at Emam Reza
Teaching Hospital, Kermanshah, Iran. We included women
with singleton pregnancy, beyond 32 weeks of gestation, with
a living fetus and cephalic presentation, who underwent nor-
mal delivery. The exclusion criteria were history of previous
PPH, history of cesarean section, any uterine scar, antepartum
hemorrhage, placental separation, placenta previa, prolonged
labor (>20 h), accelerated labor (<3 h), multiple gestations,
polyhydramnios, chorioamnionitis, and instrumental delivery
(forceps and vacuum). Moreover, pregnant women who took
anticoagulants, or those with thrombocytopenia, and the
women who underwent painless labor with epidural anesthesia
were also excluded.
The mean duration of the third stage of labor was 6.55 and
9.7 min in the experimental and control groups, respectively,with a standard deviation of 7.5 min. Based on other studies
the minimum required sample size for each group was deter-
mined to be 89 [5,7e9]. Using the mean comparison formula
for two groups, with the confidence level of 95% and power of
test at 80%.
The third stage of labor was actively managed in the two
groups by infusion of 20 IU oxytocin (Abou Rayhan, Tehran,
Iran) in 1 L Ringer’s lactate solution at a rate of 100 mL/min,
immediately after delivery of the fetus. In the control group,
1 mL normal saline was injected into the umbilical vein at the
most proximal site to the placenta after clamping and cutting
of the umbilical cord. In the experimental group, instead of
normal saline, 10 IU (1 mL) oxytocin was injected at the
same site. We waited 30 min for the symptoms of placenta
delivery (i.e., the uterus became firmer and more globular and
was displaced upward, a gush of blood occurred, and the
umbilical cord was elongated). Spontaneous delivery of the
placenta was achieved by touching the fundus and applying
pressure on the symphysis pubis by a finger and slight trac-
tion of the umbilical cord. For each participant, the duration
of the third stage of labor (the time period between the de-
livery of the fetus and the delivery of the placenta) was
recorded. The two groups were compared in terms of the
duration of the third stage of labor, hemoglobin (Hb) differ-
ence before and 6 h after delivery, mean decrease in Hb level,
and the need for manual delivery of the placenta. Manual
removal of the placenta was commonly carried out under
general sedation in the operating room, if the placenta was
not delivered 30 min after fetal delivery and there were side
effects of oxytocin (nausea and vomiting). The injection of
oxytocin and normal saline was performed by a 3rd-year
obstetrics assistant.
Data collection included age, parity, gestational age, Hb
level before and 6 h after labor, and duration of placenta de-
livery to the need for manual delivery of placenta. Comparison
of the two groups regarding the duration of the third stage of
labor, other qualitative variables, equal variance, and homo-
geneity was performed by Levene’s test and the mean com-
parison was carried out by independent sample t test.
Moreover, the qualitative variables of the two groups (need for
placenta manual delivery) were compared using the c2 test. A
p value <0.05 was considered as significant. Data analysis was
carried out using SPSS version 16.0 software.
Results
Thirty minutes after delivery of the fetus, the need for
manual delivery of the placenta was 1.1% and 5.1% in the
experimental and control groups, respectively, which was
a significant difference ( p ¼ 0.034). The duration of placental
delivery was 4.24  3.27 min in the experimental group,
which was significantly shorter than in the control group
(10.66  7.41 min) ( p < 0.001). Hb level before labor was
comparable in the experimental and control groups,
12.45  0.78 g/dL and 12.49  0.85 g/dL, respectively
( p ¼ 0.782). The Hb level 6 h after labor was higher in the
experimental than the control group (12.32  0.88 g/dL vs.
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( p ¼ 0.23). Hb decrease after labor was less in the exper-
imental than the control group (0.13 g/dL vs. 0.91 g/dL), but
the difference was not significant. Also, the mean age of the
participants did not differ significantly between the exper-
imental and control groups (26  6.33 years vs. 25.57  5.62
years) ( p ¼ 0.21). However, with regard to mean gestational
age at delivery, there was a significant difference: 38.47  1.47
weeks and 39.05  1.12 weeks in the experimental and control
groups, respectively ( p ¼ 0.03). Considering parity, 87.7% of
the experimental group and 87.8% of the control group were in
first and second parity. Mean parity of the experimental and
control groups was 1.47  0.70 compared with 1.49  0.69,
which was not a significant difference ( p ¼ 0.83). Regarding
drug side effects, only one case of nausea (1.1%) and one case
of vomiting (1.1%) were observed in the experimental group,
but there were no side effects noted in the control group
(Table 1).
Discussion
The results of our study showed that intraumbilical vein
injection of oxytocin was effective at shortening the duration
of the third stage of labor and reducing the need for manual
placental removal, but the impact on Hb concentration before
and after delivery was not obvious.
Many studies that have agreed with ours have cited the
effects of oxytocin injection on the duration of third-stage
labor, indicating a positive effect in reducing the time for
placental delivery or the third stage of labor [5,7e9]. The time
interval for placental delivery recorded in the study of Dahiya
et al was shorter than that in our two groups, which could
probably be attributed to the greater amount of fluid injected
(20 mL in their study vs. 1 mL in ours), thereby generating
larger hydraulic and mechanical effects [5].Table 1
Evaluated variables of the case and control group patients.
Variables Cases Controls Total p
Paritya No. % No. % No. %
1 58 65.2 55 61.8 113 63.5 0.83
2 20 22.5 24 27 44 24.7
3 11 12.4 10 11.2 21 11.8
Need for manual
placental removala
Yes 1 1.1 8 9 9 5.1
No 88 98.9 81 91 169 94.9 0.034
Nausea and vomitinga Yes 1 1.1 0 0 1 0.6 0.76
No 88 98.9 89 100 177 99.4
Mean preoperative Hb
(g/dL)b
12.45  0.78 12.49  0.85 0.782
Mean postoperative
Hb (g/dL)b
12.32  0.88 11.58  0.86 0.23
Difference in mean
Hb (g/dL)b
0.13 0.91 d
Mean length time of
placental
separation (min)b
4.24  3.27 10.66  7.41 <0.001
Total n ¼ 89 n ¼ 89 178
a c2 test; b Independent sample t test.In contrast, in a study carried out in Bangkok, Thailand in
1995, the two groups did not show a significant difference in
the third stage of labor [7]. The results of a study demonstrated
that the intraumbilical vein Oxytocin injection versus normal
saline group did not differ significantly with regard to spon-
taneous expulsion of the placenta within 45 minutes of de-
livery [10].
In a study carried out in Florida, USA, it was concluded
that the duration of the third stage of labor was not sig-
nificantly different between the groups receiving intravenous
oxytocin or additional intraumbilical vein oxytocin on top of
the intravenous dose. However, in the same hospital, another
study conducted on 50 patients in March 1998 found that the
duration of the third stage of labor was significantly shorter in
the experimental group [11].
In the aforementioned studies [5,9], there was a significant
fall in the mean postpartum Hb level, from 1.96 g/dL to
1.2 g/dL in the case and control groups, which showed a pos-
itive effect of intraumbilical vein oxytocin injection. The
reason why our study did not show a similar positive effect on
Hb change might be the active management of the third stage
of labor for both groups with uterotonics and appropriate
procedures.
We chose a waiting period of 30 min after fetal delivery
before proceeding with manual placental removal. Some have
recommended a time interval of 30 min [12], whereas others
have stated a range of 15e60 min [13]. Many studies have
focused on the effects of oxytocin injection in manual de-
livery of the placenta, and have reported using different doses
and volumes and methods of infusion in patients with
retained placenta [14,15e17]. In a systematic review, Carroli
et al [6] have declared the positive effects of intraumbilical
vein oxytocin injection. However, Sivalingam and Rogers
have concluded that this kind of injection is not clinically
useful for the removal of retained placenta [16,17] citing
reasons like oxytocin passage to radial and uterine vein and
not to capillaries to effect myometrial contraction and another
with possible link to oxygenase activity [15]. Our study
similar to that conducted by Gazvani et al showed the ben-
eficial effects of intraumbilical oxytocin injection in reducing
manual delivery of the placenta [10]. According to our re-
sults, the need for manual removal of the placenta was 1.1%
and 5.1% in the case and control groups, respectively.
It seems that intraumbilical vein administration of oxytocin
is an effective and practical method in shortening the duration
of the third stage of labor and decreasing the rate of manual
delivery of the placenta. However, the intervention does not
produce a similar beneficial effect in significantly reducing
Hb. Thus, further larger studies may be needed to address this
issue.Acknowledgments
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